Prm1 - Validation of Alternative “Surrogate” Clinical Endpoints in Advanced Melanoma

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV